Medtronic received information via literature regarding percutaneous pulmonary valve implantation outcomes in pediatric patients implanted with a melody bioprosthetic valve.All data were collected from a single center between april 2012 and march 2016.The study population included 19 patients (mean age 13.6 years, mean weight 46 kg), all of which were implanted with a medtronic melody bioprosthetic valve (serial numbers not provided).Among all 19 patients adverse events included: 1 immediate stent fracture and 2 groin hematoma.During follow-up echocardiography showed stable right ventricular outflow tract velocity with nothing more than mild pulmonary regurgitation in all patients.Additionally, 4 of the 19 patients had a previously implanted medtronic contegra conduit (serial numbers not provided) with noted dysfunction which was addressed with implant of a melody valve.No further details were provided.No additional adverse patient effects or product performance issues were reported.
|